Regulus Therapeutics | RGLS - Market Capitalization


Regulus Therapeutics reported $175.8M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Sanofi EUR 117.34B 2.45B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025